Avid Bioservices Inc (CDMO)

[biopharm]

What has John Springs Stafford been buying ....more CDMO or one other that would benefit due to CDMO? All puzzle pieces continue for why Stafford needed to break into PPHM BOD

Why is Stafford not returning calls???

Halozyme Licenses New ENHANZE® Targets For $25 Million Upfront Payment, Future Milestones And Royalties

10/30/2018

....
...

In addition, Roche is in Phase 1 testing with an undisclosed target. More recently, in 2017, the relationship expanded to include the right to evaluate an additional target with ENHANZE.

https://www.halozyme.com/investors/news-releases/news-release-details/2018/Halozyme-Licenses-New-ENHANZE-Targets-For-25-Million-Upfront-Payment-Future-Milestones-And-Royalties/default.aspx

__________________

Jan 21, 2019

Xencor Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider sale was by John Stafford for US$10.0m worth of shares

https://finance.yahoo.com/news/insiders-selling-xencor-inc-nasdaq-111200201.html

__________________


February 05, 2019

Roche and Xencor double down with cytokine deal

https://www.evaluate.com/vantage/articles/news/snippets/roche-and-xencor-double-down-cytokine-deal